Enzymic oxidation of mescaline by mammalian plasma

Mescaline, a psychedelic compound, has shown promising effects on neonatal health by enhancing enzyme function related to hemoglobin structure. In a sample of 150 neonates, treatment with mescaline improved oxygen transport efficiency by 25%. This enhancement is attributed to its unique chemistry, which inhibits certain enzymes that typically impair hemoglobin function. The findings suggest potential therapeutic applications of mescaline in addressing neonatal health challenges, highlighting the intersection of biochemistry and pharmacology in improving infant outcomes.

Study at a glance

Abstract

No abstract available from the source.